跳至主要内容
临床试验/NCT04903990
NCT04903990进行中(未招募)不适用

Fetal Microchimerism and Fetal Stem Cells in Breast Cancer: Analysis of Circulating Fetal Cell Sub-populations in Women With Breast Cancer. CIRCULATING FETAL CELLS AND BREAST CANCER

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2021年5月14日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
80
试验地点
1
主要终点
Percentages of fetal cells in each immune cell subpopulation.

研究概览

简要总结

After pregnancy, fetal cells remain in a woman's body for years. These cells may be involved in different physiological situations (e.g. wound healing) and diseases (e.g. cancer).The study will evaluate the level of circulating fetal immune cells in patients with breast cancer vs controls with benign breast tumors, and further characterize these fetal cells. Patients participation will be limited to accepting that an additional blood sample is collected on the day of their preop consultation and blood test.

详细描述

Breast cancer is the most common cancer in the female population. The protective mechanism associated with pregnancy is not fully understood.

During pregnancy fetal cells cross the placental barrier and may remain in the maternal circulation even for up to 30 years after childbirth. This phenomenon is called fetal microchimerism.

The presence of circulating fetal cells would have a protective role against breast cancer. However, their phenotype and role in the anti-tumor response is not explored.

The objective of the study is to identify the sub-population (s) of circulating fetal immune cells that may have an impact on the processes of carcinogenesis in breast cancer, in the context of fetal microchimerism.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • women aged 18-50
  • having had a male child
  • informed and not having objected to participating in the research.
  • having a diagnosis of breast cancer
  • operated on for benign breast tumors
  • cancer free

排除标准

  • autoimmune disease
  • immunomodulatory treatment
  • history of cancer other than breast cancer
  • ongoing hormonal treatment
  • women not affiliated to the social security
  • under AME (state medical aid)
  • under tutorship / curatorship

结局指标

主要结局

Percentages of fetal cells in each immune cell subpopulation.

时间窗: 3 years

Using fluorescence activated cell sorting method.

次要结局

  • Activation markers.(3 years)
  • Cytotoxicity markers.(3 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验